Huiying Han

Huiying Han is an Associate Director and Team Lead in ADC Oncology at AstraZeneca, where they focus on drug discovery and development in cancer research. With a Ph.D. in Medicinal Chemistry from Shenyang Pharmaceutical University, Huiying previously served as a Senior Research Associate at Northwestern University, investigating molecular mechanisms of cancer therapies and developing small molecule inhibitors. Their postdoctoral work at the National Institutes of Health centered on the cellular matrix protein TIMP2 and its potential as a biological cancer therapy, leading to significant publications in prestigious journals. Throughout their career, Huiying has demonstrated expertise in target identification, biomarker discovery, and the efficacy evaluation of drug candidates.